Beneficial effect of olanzapine in schizophrenic patients with obsessive-compulsive symptoms

International Clinical Psychopharmacology

Volumn 15, Issue 3, 2000, Pages 169-173

  Poyurovsky, M ^a   Dorfman Etrog, P ^b,c   Hermesh, Haggai ^b,c   Munitz, H ^b,c   Tollefson, G D ^d   Weizman, A ^b,c  

^a Technion Medical School   (Israel)

^b GEHA MENTAL HEALTH CENTER   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

^d ELI LILLY AND COMPANY   (United States)

Author keywords

Clozapine; Dopamine; Obsessive compulsive symptoms; Olanzapine; Schizophrenia; Serotonin

Indexed keywords

CHLORPROMAZINE; CLOMIPRAMINE; CLOTIAPINE; CLOZAPINE; FLUOXETINE; HALOPERIDOL; LEVOMEPROMAZINE; NEUROLEPTIC AGENT; OLANZAPINE; PAROXETINE; PERPHENAZINE; RISPERIDONE; SULPIRIDE;

ADULT; ARTICLE; CASE REPORT; CLINICAL TRIAL; COMORBIDITY; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HUMAN; HYPERSALIVATION; MALE; OBESITY; OBSESSION; PRIORITY JOURNAL; RATING SCALE; SCHIZOPHRENIA;

EID: 0034034191     PISSN: 02681315     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004850-200015030-00006     Document Type: Article

References (29)

1. Al-Mulhim A, Atwal S, Coupland NJ (1998) Provocation of obsessive-compulsive behavior and tremor by olanzapine [letter]. Can J Psychiatry 43:645.
2. Baker RW, Chengappa KNR, Baird LR, Steinguard S, Christ M, Schooler N (1992) Emergence of obsessive-compulsive symptoms during treatment with clozapine. J Clin Psychiatry 53:439-442.
3. Baker RW, Ames D, Umbricht DS, Chengappa KM, Schooler NR (1996) Obsessive-compulsive symptoms in schizophrenia: a comparison of olanzapine and placebo. Psychopharmacol Bull 32:89-93.
4. Berman I, Kalinowski A, Berman SM, Lengva J, Green IL (1995a) Obsessive and compulsive symptoms in chronic schizophrenia. Comp Psychiatry 36:6-10.
5. Berman I, Sapers BL, Chang HHJ, Losonczy MF, Schmildler J, Green AI (1995b) Treatment of obsessive-compulsive symptoms in schizophrenic patients with clomipramine. J Clin Psychopharmacol 15:206-210.
6. Bermanzohn PC, Porto L, Arlow PB, Axelrod S, Sastry G, Stronger R, et al. (1997) Are some neuroleptic-refractory symptoms of schizophrenia really obsessions? CNS Spectrums 2:51-57.
7. Bymaster FP, Calligaro DO, Falcone JF, Marsh RD, Moore NA, Tye NC, et al. (1996) Radioreceptor binding profile of the atypical antipsychotic olanzapine. Neuropsychopharmacology 14:87-96.
8. Dossenbach M, Belmaker RH, Elizur A (1997) Olanzapine in patients with clozapine treatment failure [abstract]. Fifth World Congress of Biological Psychiatry, Nice, France.
9. Eisen JL, Beer DA, Pato MT, Venditto TA, Rasmussen SA (1997) Obsessive-compulsive disorder in patients with schizophrenia or schizo-affective disorder. Am J Psychiatry 154:271-273.
10. Fenton WS, McGlashan TH (1986) The prognostic significance of obsessive-compulsive symptoms in schizophrenia. Am J Psychiatry 143:437-441.
11. Kapur S, Remington G (1996) Serotonin-dopamine interaction and its relevance to schizophrenia. Am J Psychiatry 153:446-476.
12. Kopala L, Honer WG (1994) Risperidone, serotonergic mechanisms, and obsessive-compulsive symptoms in schizophrenia. Am J Psychiatry 151:1714-1715.
13. LaPorta LD (1994) More on obsessive-compulsive symptoms and clozapine. J Clin Psychiatry 55:312.
14. McDougle CJ, Fleischmann RL, Epperson CN, Wasylink S, Leckman JF, Price LH (1995) Risperidone addition in fluvoxamine-refractory obsessive-compulsive disorder: three cases. J Clin Psychiatry 34:1147-1152.
15. Motard J-P, de la Sablonniere J-F (1999) Olanzapine-induced obsessive-compulsive disorder [letter]. Am J Psychiatry 156:799-800.
16. Morrison D, Clark D, Goldfarb G, McCoy L (1998) Worsening of obsessive-compulsive symptoms following treatment with olanzapine [letter]. Am J Psychiatry 155:855.
17. Potenza MN, Wasylink S, Longhurst JG, Epperson CN, McDougle CJ (1998) Olanzapine augmentation of fluoxetine in the treatment of refractory obsessive-compulsive disorder [letter]. J Clin Psychopharmacol 18:423-424.
18. Poyurovsky M, Hermesh H, Weizman A (1996) Fluvoxamine treatment in clozapine-induced obsessive-compulsive symptoms in schizophrenic patients. Clin Neuropharmacol 19:305-313.
19. Poyurovsky M, Weizman A (1997) Beneficial effect of clozapine in schizophrenic patients with comorbid obsessive-compulsive symptoms [abstract]. APA Annual Meeting, San Diego, CA, (b): 136.
20. Poyurovsky M, Bergman Y, Shoshani D, Schneidman M, Weizman A (1998) Emergence of obsessive-compulsive symptoms and tics during clozapine withdrawal. Clin Neuropharmacol 21:97-100.
21. Poyurovsky M, Weizman A (1998) Intravenous pulse-loading clomipramine in schizophrenic patient with obsessive-compulsive symptoms [letter]. Am J Psychiatry 155:993.
22. Poyurovsky M, Isakov V, Hromnikov S, Modai I, Rauchberger R, Schniedman M, Weizman A (1999) Fluvoxamine treatment of obsessive-compulsive symptoms in schizophrenic patients: an add-on open study. Int Clin Psychopharmacol 14:95-100.
23. Ravizza L, Barzega G, Bellino S, Bogetto F, Maina G (1996) Therapeutic effect and safety of adjunctive resperidone in refractory obsessive-compulsive disorder (OCD). Psychopharmacol Bull 32:677-682.
24. Richelson E (1996) Preclinical pharmacology of neuroleptics: focus on new generation compounds. J Clin Psychiatry 57 (Suppl 11):4-10.
25. Sasson Y, Zohar J (1996) New developments in obsessive-compulsive disorder research: implications for clinical management. Int Clin Psychopharmacol 11 (Suppl 5):3-12.
26. Saxena S, Wang D, Bystritsky A, Baxter LR Jr (1996) Risperidone augmentation of SRI treatment for refractory obsessive-compulsive disorder. J Clin Psychiatry 57:303-306.
27. Tollefson GD, Sanger TM (1997) Negative symptoms: a path analytic approach to a double-blind, placebo- and haloperidol-controlled clinical trial with olanzapine. Am J Psychiatry 154:466-474.
28. Tollefson GD, Beasley CM, Trans PV, Street JS, Krueger JA, Tamura RN, et al. (1997) Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trial. Am J Psychiatry 154:457-465.
29. Zohar J, Kaplan Z, Benjamin J (1993) Clomipramine treatment of obsessive compulsive symptomatology in schizophrenic patients. J Clin Psychiatry 54:385-388.